Product ID |
Product Name |
CAS# |
Purity |
Y3150490 |
Atorvastatin Impurity F |
1371615-56-3 |
95% |
Y1343687 |
Potassium hexafluoraluminate |
13775-52-5 |
18% |
Y3289490 |
Glyco-diosgenin |
1402423-29-3 |
99% |
Y1248576 |
PF 05085727 - Bio-X |
1415637-72-7 |
95% |
Y1244143 |
2,3,6,2',3',4',6'-Hepta-O-acetyl-a-D-cellobiosyl bromide |
14227-66-8 |
98% |
Y3150634 |
4,4,4-Trifluorobutyraldehyde hydrate |
1448773-75-8 |
95% |
Y3135894 |
9-Phenyl-9H,9'H-2,3'-bicarbazole |
1382955-10-3 |
98.0% |
Y3305348 |
Calcium-Like Peptide H-Val-Ala-Ile-Thr-Val-Leu-Val-Lys-OH |
145224-99-3 |
CALP1 =95% |
Y1313766 |
2,4,4-Trimethylpentan-2-amine Hydrobromide |
1093859-61-0 |
97% |
Y1313636 |
2,4,4-Trimethylpentan-2-amine Hydrochloride |
58618-91-0 |
98% |
Y1248482 |
Sulfur Dioxide 1-Methylpyrrolidine Adduct |
2098851-56-8 |
96% |
Y3150611 |
H-Glu-Pro-Gln-Tyr(PO3H2)-Glu-Glu-Ile-Pro-Ile-Tyr-Leu-OH |
147612-86-0 |
98.94% |
Y3317557 |
Gynostemma P.E. |
15588-68-8 |
95% |
Y3314020 |
2-Chloro-4-nitrophenyl 4-O-b-D-galactopyranosylmaltoside |
157381-11-8 |
98% |
Y3128959 |
cis-Zeatin riboside |
15896-46-5 |
98% |
Y3308372 |
RVG-9R trifluoroacetate salt H-Tyr-Thr-Ile-Trp-Met-Pro-Glu-Asn-Pro-Arg-Pro-Gly-Thr-Pro-Cys-Asp-Ile-Phe-Thr-Asn-Ser-Arg-Gly-Lys-Arg-Ala-Ser-Asn-Gly-Gly-Gly-Gly-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH trifluoroacetate salt |
1678417-57-6 |
98% |
Y3150539 |
Methyl 2-propylprolinate |
1690441-76-9 |
95% |
Y1248536 |
Ac-Asp-Glu-Val-Asp-AMC ammonium salt |
169332-61-0 |
99% |
Y1248567 |
Nociceptin trifluoroacetate salt |
170713-75-4 |
99% |
Y3150621 |
2-(chloromethyl)-5-(pyrrolidin-1-yl)-1,3,4-oxadiazole |
1700444-24-1 |
95% |
Y3150615 |
3,5-dimethyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine |
1701494-61-2 |
95% |
Y1252817 |
Benzo[d]thiazol-7-ylmethanol |
1780141-37-8 |
95% |
Y3150632 |
2-Chloro-5,6,7,8-tetrahydroquinazolin-4(3H)-one |
178308-51-5 |
95% |
Y3135872 |
5'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine |
182496-00-0 |
98% |
Y3150622 |
rac-2-methyl-6-{1-[(1R,2R)-2-methylcyclopropyl]-1H-1,2,3,4-tetrazol-5-yl}aniline, trans |
1807890-94-3 |
95% |
Y3150624 |
rac-1-[(3R,4S)-4-methoxyoxolan-3-yl]-1H-1,2,3-triazole-4-carboxylic acid, trans |
1807891-04-8 |
95% |
Y3151261 |
rac-[(2R,5S)-5-phenyloxolan-2-yl]methanamine hydrochloride, cis |
1807891-08-2 |
95% |
Y3151274 |
rac-(2R,3R)-2-phenyloxolane-3-carbohydrazide, trans |
1807912-18-0 |
95% |
Y3151265 |
methyl 3-amino-5-fluoro-4-methoxybenzoate |
329-46-4 |
95% |
Y3151266 |
7-methoxy-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one |
32900-19-9 |
95% |
Y3151255 |
4-HYDROXY-4-(PROPAN-2-YL)CYCLOHEXAN-1-ONE |
32936-69-9 |
95% |
D961540 |
2-CHLORO-6-METHOXY-1,5-NAPHTHYRIDINE |
27017-65-8 |
95% |
D775082 |
5-bromo-6,7-dihydro-1H-indazol-4(5H)-one, 5-bromo-1,5,6,7-tetrahydroindazol-4-one |
1235325-49-1 |
95% |
D775086 |
4-[(3-METHOXYPHENYL)AMINO]THIANE-4-CARBOXYLICACID |
1281266-49-6 |
95% |
Y1252257 |
3-OXO-OCTAHYDROINDOLIZINE-6-CARBOXYLIC ACID |
1934599-03-7 |
95% |
D963189 |
3-bromo-5-((4-methoxybenzyl)oxy)benzaldehyde |
1068604-40-9 |
95% |
D775087 |
(S)-2-(dibenzylamino)butan-1-ol |
249922-60-9 |
95% |
Y1341206 |
(R)-benzyl 2-oxooxazolidine-5-carboxylate |
169048-84-4 |
96% |
D775089 |
3-hydroxy-2-methylpropyl pivalate |
914802-22-5 |
95% |
D775090 |
4-(3-hydroxypropoxy)benzoic acid |
46350-87-2 |
95% |
D775091 |
(3-(ethoxycarbonyl)-5-ethyl-1-methyl-1H-pyrazol-4-yl)boronic acid |
1251760-88-9 |
95% |
Y1244029 |
2-Chloro-4-(methylthio)-7H-pyrrolo[2,3-d]pyrimidine |
1192711-79-7 |
97% |
Y1248505 |
5,6-Dichloro-N-methylpyrimidin-4-amine |
1428252-93-0 |
97% |
Y3155138 |
4-Pyrimidinemethanol, 2-chloro-6-methyl- |
181363-21-3 |
95% |
Y3159331 |
LEE011-d6 |
1328934-40-2 |
95% |
Y1319439 |
tert-butyl 4-(4-oxocyclohexyl)piperazine-1-carboxylate |
1262409-94-8 |
95% |
Y3317649 |
Momelotinibdihydrochloride |
1380317-28-1 |
98% |
Y1340803 |
ACT462206 |
1361321-96-1 |
99% |
Y3150618 |
Necrosulfonamide-d4 |
1795144-22-7 |
99% |
Y3293431 |
(±)-AtovaquoneImpurityC |
1809464-27-4 |
95% |
Y3135889 |
N,N’-Bis[3-(trifluoromethyl-4-cyanophenyl)thiourea |
1839619-50-9 |
98% |
Y3150603 |
3-Amino-4-(2,4,5-trifluorophenyl)butanylSitagliptin |
2072867-07-1 |
95% |
Y1340395 |
2,2-Dimethyl-3-(4-methoxyphenyl)propanoicAcid |
29206-06-2 |
97% |
Y3150610 |
1,6-Epoxyisodihydrocarvone |
39903-97-4 |
95% |
Y3150617 |
2-Bromopropane-d6 |
52809-76-4 |
99%D |
Y3315771 |
9-DimethylaminoMinocycline |
601455-95-2 |
95% |
Y3136019 |
N,N-DimethylphosphoramidochloridicAcid[(2S,6R)-6-[4-(Benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-4-(triphenylmethyl)-2-morpholinyl]methylEster |
956139-21-2 |
98% |
Y1248506 |
Merbarone |
97534-21-9 |
99% |
Y3315018 |
1,2,3,9-Tetrahydro-3-(1H-imidazol-1-ylmethyl)-9-methyl-4H-carbazol-4-one(OndansetronImpurityG) |
99614-03-6 |
98% |
Y3315985 |
4-Bromo-3-(methylsulfanyl)pyridine |
1394291-44-1 |
95% |
Y3139088 |
(5-AMINO-1-METHYL-1H-PYRAZOL-3-YL)-METHANOL |
1224888-30-5 |
95% |
Y3139067 |
N,6-dimethyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine |
1225057-70-4 |
95% |
Y3139090 |
1-[(4-fluorophenyl)methyl]cyclopentane-1-carboxylic acid |
1225506-32-0 |
95% |
Y3139080 |
(3-chlorophenyl)(2-fluorophenyl)methanamine |
1225577-91-2 |
95% |
Y1244126 |
[8]Cycloparaphenylene |
1217269-85-6 |
95% |
Y3135887 |
Cesium Lead Tribromide (Low water content) |
15243-48-8 |
98% |
Y1306151 |
1-Methyl-3-(4-methylcyclohexyl)benzene |
93536-69-7 |
95% |
Y3150519 |
2-cyanobutanyl-2-yl 3,5-dimethyl-1H-pyrazole-1-carbodithioate |
1883264-36-5 |
95% |
Y3135900 |
2-(Butylthiocarbonothioylthio)propanoic acid |
480436-46-2 |
97% |
Y1244142 |
4,4'-Dimethyl-2,2'-bipiperidine |
1378896-71-9 |
98% |
Y3313061 |
4-(3,6-Di-tert-butyl-9H-carbazol-9-yl)aniline |
255829-30-2 |
98% |
Y3288891 |
N-[2-(Methacryloyloxy)ethyl]-N,N-dimethylbutan-1-aminium Bis(trifluoromethanesulfonyl)imide |
1616483-28-3 |
98% |
Y1315286 |
1-Methyl-1-pentylpyrrolidinium Bis(trifluoromethanesulfonyl)imide |
380497-17-6 |
98% |
Y1244167 |
cvxIAA |
2127037-35-6 |
98% |
Y1337683 |
Chondroitin disaccharide di-4S disodium salt |
136144-56-4 |
95% |
Y3305046 |
H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH |
138028-00-9 |
99% |
Y3128235 |
Atezolizumab |
1380723-44-3 |
~60mg/ml(in buffer),98% |
Y3128234 |
Fmoc-Cys((R)-2,3-di(palmitoyloxy)-propyl)-OH |
139573-77-6 |
95% |
Y1244054 |
Fmoc-Cys((S)-2,3-di(palmitoyloxy)-propyl)-OH |
139573-78-7 |
95% |
Y1335177 |
2,3,6,2',3',4',6'-Hepta-O-acetyl-a-D-maltosyl bromide |
14257-35-3 |
98% |
Y3128250 |
N4-Benzoyl-2'-deoxy-5'-O-DMT-2',2'-difluorocytidine 3'-CE phosphoramidite |
142808-44-4 |
97% |
Y3150513 |
N-[2-(1H-Imidazol-5-yl)ethyl]-1-(1H-indazol-3-yl)-5-oxo-3-pyrrolidinecarboxamide |
1436004-46-4 |
99.60% |
Y1300929 |
2',3'-Cyclic guanosine monophosphate-adenosine monophosphate |
1441190-66-4 |
95% |
Y3287089 |
Tris[4-(1,1-dimethylethyl)-2-(1H-pyrazol-1-yl)pyridine]cobalt salt with 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide (1:3) |
1447938-61-5 |
99%(NMR) |
Y3150627 |
5-METHANESULFONYL-2-METHYLPYRIDINE |
1392213-58-9 |
95% |
Y3150625 |
2-(DIMETHYLAMINO)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID |
1393746-53-6 |
95% |
Y3150631 |
3-{[(9H-fluoren-9-ylmethoxy)carbonyl](2-methylpropyl)amino}propanoic acid |
1393817-23-6 |
95% |
Y1248562 |
1,2,4-Tribromo-5-iodobenzene |
366496-32-4 |
98% |
Y1344312 |
TWS 119 - Bio-X |
1507095-58-0 |
98% |
Y3138961 |
2-Amino-3-(1-carboxyethyldisulfanyl)propanoic acid |
15476-49-0 |
95% |
Y3138969 |
2'-Azidoethyl a-mannopyranoside |
155196-97-7 |
95% |
Y3128770 |
6-Amino-D-luciferin |
161055-47-6 |
98% |
Y1344064 |
Boc-N-Methyl-D-norleucine |
161450-84-6 |
97% |
Y3308147 |
SYBR Green 1 - Solution in DMSO |
163795-75-3 |
95% |
Y1248563 |
4-Amino-3,5-dichlorobenzylamine |
164648-75-3 |
90% |
Y1344138 |
Astressin trifluoroacetate salt H-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo(-Glu-Ala-His-Lys)-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 trifluoroacetate salt |
170809-51-5 |
96% |
Y3308600 |
Tetrindole mesylate |
170964-68-8 |
99% |
Y3136012 |
Pelargonin chloride |
17334-58-6 |
95% |
Y3158472 |
4-Nitrophenyl b-D-xylotrioside |
173468-29-6 |
95% |
Y1313348 |
N,9,9-Triphenyl-9H-fluoren-2-amine |
860465-14-1 |
98% |